Adherence to Antipsychotic Adverse Effect Monitoring Among a Referred Sample of Children with Intellectual Disabilities

Journal of Child and Adolescent Psychopharmacology
Khodadad R Javaheri, John D McLennan

Abstract

Despite frequent use of antipsychotic medications to target severe behavioral problems among children with intellectual disabilities (ID), there is little information as to the extent to which adverse effect monitoring is in place for this population. The aim of this pilot study was to determine the extent to which monitoring for adverse effects was documented in health records of a cohort of children with ID who had been prescribed antipsychotic medication. Data were available on all children referred to a mental health clinic at a children's hospital in Canada who had ID and behavioral difficulties with intake appointments between September 1, 2016 and November 30, 2017. Charts of all those on antipsychotic medications were reviewed for a 12-week period to determine the extent to which adverse effect monitoring was documented using the parameters stipulated by the Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA), including laboratory, anthropometric, and neurological measures. The database was composed of 47 patients of whom 25 were on antipsychotics (56% boys; mean age 13 [SD 3] years). The most commonly used antipsychotic was risperidone (48%). The extent of adherence to the g...Continue Reading

References

Aug 10, 2000·Journal of Child and Adolescent Psychopharmacology·A ZuddasC Cianchetti
Oct 20, 2001·Journal of Child and Adolescent Psychopharmacology·J A HellingsS R Schroeder
Aug 2, 2002·The New England Journal of Medicine·James T McCrackenUNKNOWN Research Units on Pediatric Psychopharmacology Autism Network
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Feb 27, 2004·The American Journal of Clinical Nutrition·Ian JanssenRobert Ross
Oct 31, 2006·Journal of Child and Adolescent Psychopharmacology·Joan LubyEdward Spitznagel
Apr 7, 2010·Archives of Pediatrics & Adolescent Medicine·Elaine H MorratoJohn W Newcomer
Dec 6, 2011·Journal of Child and Adolescent Psychopharmacology·Tamara PringsheimScott B Patten
Mar 1, 2012·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Joyce Nolan HarrisonDeborah Gross
May 2, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Rebecca RonsleyConstadina Panagiotopoulos
Aug 8, 2012·Archives of General Psychiatry·Mark OlfsonChristoph U Correll
Dec 12, 2012·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Scott B PattenLauren Bresee
Aug 27, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanUNKNOWN American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)
Oct 30, 2013·Autism : the International Journal of Research and Practice·Jane R SchubartDouglas Leslie
Feb 26, 2014·Journal of Child and Adolescent Psychopharmacology·Logan K WinkCraig A Erickson
Jul 1, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Tamara PringsheimThomas D L Steeves
Jan 29, 2016·Journal of Autism and Developmental Disorders·Lisa M RuizDeborah A Bilder
May 31, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·Su Young ParkChristoph U Correll
Jul 9, 2016·Journal of Child and Adolescent Psychopharmacology·Yesie YoonCraig A Erickson
Nov 7, 2016·Journal of Autism and Developmental Disorders·Jeanne M MaddenLisa A Croen
Dec 6, 2017·International Journal of Mental Health Nursing·Mary CoughlinSarosh Khalid-Khan
May 26, 2018·JAMA : the Journal of the American Medical Association·Craig M HalesCynthia L Ogden
Jun 6, 2018·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jennifer PillayNormand Carrey

❮ Previous
Next ❯

Methods Mentioned

BETA
SGA
sedation

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
Tamara PringsheimDavid Gardner
Journal of Child and Adolescent Psychopharmacology
Logan K WinkCraig A Erickson
© 2022 Meta ULC. All rights reserved